Jane Street Group LLC reduced its holdings in Dolby Laboratories, Inc. (NYSE:DLB - Free Report) by 86.3% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 6,272 shares of the electronics maker's stock after selling 39,358 shares during the quarter. Jane Street Group LLC's holdings in Dolby Laboratories were worth $480,000 at the end of the most recent reporting period.
Other hedge funds also recently modified their holdings of the company. State Street Corp grew its holdings in shares of Dolby Laboratories by 1.5% during the third quarter. State Street Corp now owns 1,931,586 shares of the electronics maker's stock worth $147,824,000 after buying an additional 29,289 shares in the last quarter. Disciplined Growth Investors Inc. MN lifted its position in Dolby Laboratories by 0.8% during the 2nd quarter. Disciplined Growth Investors Inc. MN now owns 1,402,623 shares of the electronics maker's stock worth $111,130,000 after buying an additional 10,852 shares in the last quarter. Boston Trust Walden Corp boosted its stake in shares of Dolby Laboratories by 185.3% during the 3rd quarter. Boston Trust Walden Corp now owns 1,075,076 shares of the electronics maker's stock worth $82,276,000 after buying an additional 698,283 shares during the last quarter. Mackenzie Financial Corp grew its holdings in shares of Dolby Laboratories by 3.5% in the 2nd quarter. Mackenzie Financial Corp now owns 1,010,230 shares of the electronics maker's stock valued at $80,041,000 after acquiring an additional 33,848 shares in the last quarter. Finally, Dimensional Fund Advisors LP increased its position in shares of Dolby Laboratories by 27.0% in the second quarter. Dimensional Fund Advisors LP now owns 792,828 shares of the electronics maker's stock valued at $62,817,000 after acquiring an additional 168,744 shares during the last quarter. Institutional investors and hedge funds own 58.56% of the company's stock.
Insider Transactions at Dolby Laboratories
In other Dolby Laboratories news, CAO Ryan Nicholson sold 10,500 shares of the business's stock in a transaction that occurred on Tuesday, November 26th. The shares were sold at an average price of $80.18, for a total transaction of $841,890.00. Following the completion of the transaction, the chief accounting officer now directly owns 24,364 shares in the company, valued at $1,953,505.52. The trade was a 30.12 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Peter C. Gotcher sold 6,079 shares of the firm's stock in a transaction on Thursday, November 21st. The shares were sold at an average price of $78.96, for a total value of $479,997.84. Following the completion of the sale, the director now directly owns 37,593 shares in the company, valued at approximately $2,968,343.28. This represents a 13.92 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 164,429 shares of company stock worth $12,991,048 over the last quarter. Company insiders own 38.39% of the company's stock.
Dolby Laboratories Price Performance
Dolby Laboratories stock traded down $0.33 during mid-day trading on Tuesday, hitting $77.79. 281,112 shares of the company's stock traded hands, compared to its average volume of 318,278. The firm has a 50 day simple moving average of $77.23 and a two-hundred day simple moving average of $75.60. Dolby Laboratories, Inc. has a fifty-two week low of $66.35 and a fifty-two week high of $86.37. The stock has a market cap of $7.42 billion, a price-to-earnings ratio of 28.70 and a beta of 0.98.
Dolby Laboratories Increases Dividend
The business also recently declared a quarterly dividend, which was paid on Tuesday, December 10th. Investors of record on Tuesday, December 3rd were paid a $0.33 dividend. The ex-dividend date was Tuesday, December 3rd. This represents a $1.32 dividend on an annualized basis and a yield of 1.70%. This is a positive change from Dolby Laboratories's previous quarterly dividend of $0.30. Dolby Laboratories's dividend payout ratio is 48.71%.
Wall Street Analysts Forecast Growth
A number of research firms have weighed in on DLB. Barrington Research restated an "outperform" rating and issued a $100.00 price target on shares of Dolby Laboratories in a research note on Wednesday, November 20th. Rosenblatt Securities raised their target price on shares of Dolby Laboratories from $98.00 to $100.00 and gave the company a "buy" rating in a research note on Wednesday, November 20th. Finally, StockNews.com raised shares of Dolby Laboratories from a "buy" rating to a "strong-buy" rating in a research report on Wednesday, December 4th.
View Our Latest Stock Analysis on Dolby Laboratories
About Dolby Laboratories
(
Free Report)
Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.
Further Reading
Before you consider Dolby Laboratories, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Dolby Laboratories wasn't on the list.
While Dolby Laboratories currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.